Stanford Diabetes Research Center

斯坦福糖尿病研究中心

• 批准号: 10197902
• 负责人: Seung K Kim
• 金额: $ 150.52万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-15 至 2022-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10197902
• 关键词: ATAC-seq; Abbreviations; American; Apple; Area; Award; Awareness; Basic Science; Beta Cell; Biological Assay; Biological Sciences; Biomedical Research; California; Cardiovascular Diseases; Cardiovascular system; Caring; Cellular biology; Chemistry; Child Health; Chromatin; Clinical; Clinical Research; Clinics and Hospitals; Collaborations; Communication; Communities; Development; Diabetes Mellitus; Diabetes prevention; Diagnosis; Discipline; Education; Engineering; Environment; Event; Evolution; Faculty; Family; Fostering; Foundations; Funding; Future; Genetic; Genomics; Goals; Growth; Health; Health Personnel; Heart; Human; Humanities; Immunologic Monitoring; Industrialization; Institutes; Insulin-Dependent Diabetes Mellitus; Interdisciplinary Study; International; Kidney; Kidney Diseases; Knowledge; Leadership; Learning; Letters; Malignant neoplasm of pancreas; Medicine; Mentors; Metabolism; Mission; Modernization; Natural regeneration; Non-Insulin-Dependent Diabetes Mellitus; Obesity; Occupations; Pancreas; Patients; Pediatric Hospitals; Phenotype; Principal Investigator; Research; Research Institute; Research Personnel; Research Support; Research Training; Resources; Risk-Taking; San Francisco; Schools; Science; Scientist; Services; Silicon; Strategic Planning; Supervision; Technology; Training; Training Programs; Translating; Translational Research; Translations; United States National Institutes of Health; Universities; Work; base; chimeric antigen receptor T cells; chronic pancreatitis; clinical care; improved; innovation; insulin sensitivity; islet; mHealth; medical schools; member; multidisciplinary; next generation; outreach; outreach program; programs; ranpirnase; recruit; research clinical testing; research study; scientific organization; stroke trials

Center overview abstract The Stanford Diabetes Research Center (SDRC) embodies the culmination of a long-term strategic plan by the Stanford University School of Medicine to create a premier program founded on a base of superb, collaborative investigators studying basic, clinical and translational problems focused on improving diabetes care. Support of this P30 application will leverage diabetes research at Stanford University by providing key resources dedicated to supporting research, training and clinical activities focused on diabetes. Stanford has a well- known tradition and reputation for academic excellence, scientific innovation, and clinical care, united in a true University located on a single campus that facilitates and encourages interaction between scientists and clinicians from different disciplines. Stanford is the heart of Silicon Valley, an epicenter of innovation and calculated risk-taking, whose technology companies, start-ups, and mobile health companies partner with SDRC faculty in unique and growing collaborations to advance diabetes research and care. The SDRC is comprised of 94 investigators in 23 departments from the Schools of Medicine, Engineering, and Humanities & Sciences. The SDRC mission is to foster innovation, new knowledge, and training in basic and translational diabetes-related research, leading to improved diagnosis, treatment and prevention of diabetes and its complications. The SDRC consists of: 1) Administrative Component that coordinates the scientific, organizational, and outreach activities; 2) Biomedical Research Component that recruits and selects SDRC- affiliated investigators and supervises the research cores that facilitate and enhance their research; 3) Pilot and Feasibility Program that facilitates the development of new investigators into independent scientists and encourages scientists in other fields to enter the field of diabetes research; and 4) Enrichment, Training, and Outreach Program that fosters an environment conducive to collaborative, interdisciplinary research on diabetes. NIH support for the SDRC is greatly amplified by: 1) Stanford's sustained commitment to provide research space and additional financial resources; 2) a diverse, comprehensive array of research core services at Stanford, which allows NIH funds to support unique, diabetes-related research cores; and 3) collaborative efforts with other NIH-funded research centers at Stanford. The SDRC is evolving and dynamic, including additions to its investigator base and research areas, expanded focus on clinical and translational research, and evolution of core support to provide unique, indispensable core services devoted to diabetes research. Because of the strategic plan to create a strong Stanford Diabetes Research Center, and the culture of innovation this Center at Stanford creates, SCRC-affiliated investigators have made and are poised to continue making important scientific contributions related to diabetes, obesity, and metabolism.

中心概述摘要 斯坦福大学糖尿病研究中心（SDRC）体现了长期战略计划的高潮， 斯坦福大学医学院创建一个一流的计划，建立在一流的，合作的基础上， 研究基础、临床和转化问题的研究人员集中于改善糖尿病护理。支持 这个P30应用程序将通过提供关键资源来利用斯坦福大学的糖尿病研究 致力于支持糖尿病的研究、培训和临床活动。斯坦福大学有一个很好的- 著名的传统和声誉的学术卓越，科学创新和临床护理，团结在一个真正的 大学坐落在一个单一的校园，促进和鼓励科学家之间的互动， 来自不同学科的临床医生。斯坦福大学是硅谷的心脏，是创新的中心， 他们的科技公司、初创企业和移动的医疗保健公司与 SDRC教师在独特的和不断增长的合作，以推进糖尿病研究和护理。SDRC是 由来自医学院、工程学院和人文学院23个系的94名研究人员组成， 以理工科为重SDRC的使命是促进创新，新知识，并在基础和转化培训 糖尿病相关的研究，导致改善诊断，治疗和预防糖尿病及其 并发症SDRC包括：1）行政部门，负责协调科学， 2）招募和选择SDRC的生物医学研究部分- 附属研究人员并监督促进和加强其研究的研究核心; 3）试点 和可行性计划，促进新的研究人员发展成为独立的科学家， 鼓励其他领域的科学家进入糖尿病研究领域; 4）丰富，培训， 推广计划，促进有利于合作的环境，跨学科的研究 糖尿病NIH对SDRC的支持被以下因素大大放大：1）斯坦福大学的持续承诺， 研究空间和额外的财政资源; 2）多样化，全面的研究核心服务 在斯坦福大学，它允许NIH基金支持独特的，糖尿病相关的研究核心;和3）合作 与其他NIH资助的研究中心在斯坦福大学的努力。SDRC不断发展且充满活力，包括 增加其研究者基础和研究领域，扩大对临床和转化研究的关注， 和核心支持的演变，以提供独特的，不可或缺的核心服务，致力于糖尿病研究。 由于建立一个强大的斯坦福大学糖尿病研究中心的战略计划，以及 斯坦福大学的这个中心创造了创新，SCR附属的研究人员已经做出并准备继续下去 在糖尿病、肥胖症和新陈代谢方面做出了重要的科学贡献。